Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Rosetta Capital is a UK-based venture capital firm that specializes in the life sciences and medical device sectors. Founded over 20 years ago, the firm has established a strong presence in the global investment landscape, primarily focusing on North America and Europe. The firm has executed numerous transactions, leveraging its extensive experience to navigate complex investment opportunities.
Currently, Rosetta Capital manages a diverse portfolio of over 50 companies, showcasing its commitment to transforming healthcare through strategic investments. The firm operates from two office locations: Oxford and London, and maintains a robust network of limited partners that support its investment activities.
Rosetta Capital invests in the life sciences and medical device sectors, targeting seed, Series A, Series B, and growth equity stages. The firm employs a global investment strategy, with a particular emphasis on North America and Europe. Rosetta Capital utilizes direct secondary transactions to provide flexible liquidity solutions to both investors and corporations.
The firm has made over 50 venture investments and has a proven track record in managing complex transactions. Rosetta Capital actively supports its portfolio companies through follow-on financings and strategic engagement with management teams and boards, ensuring that they have the resources needed to succeed.
Rosetta Capital's portfolio includes a mix of exited and private companies, demonstrating its diverse investment strategy. Notable portfolio companies include:
Jonathan Hepple - Managing Partner. Hepple has extensive experience in venture capital and has led numerous successful investments in the life sciences sector.
Ken MacLeod - Partner. MacLeod brings a wealth of knowledge in healthcare investments and has been instrumental in developing Rosetta Capital's investment strategy.
Michael Forer - Partner. Forer has a strong background in managing complex transactions and has played a key role in the firm's portfolio management.
Matthew James - Chief Financial Officer. James oversees the financial operations of the firm, ensuring sound fiscal management and reporting.
Donovan Leung - Investment Manager. Leung focuses on sourcing and evaluating new investment opportunities within the life sciences sector.
Melissa Riachi - Investment Analyst. Riachi supports the investment team with market research and analysis, contributing to the firm's decision-making process.
To pitch to Rosetta Capital, founders should send their proposals via email to info@rosettacapital.com. A well-structured pitch deck that includes the business model, market analysis, and financial forecasts is essential. Response times may vary, so patience is advised.
In recent months, Rosetta Capital has continued to expand its portfolio, focusing on investments in the life sciences sector. The firm has successfully exited several companies, including Aprea Pharmaceutical, NovImmune, and Immunocore, showcasing its ability to identify high-potential startups.
Rosetta Capital remains active in the venture capital space, with ongoing efforts to support its portfolio companies through follow-on financings and strategic engagement. The firm’s commitment to transforming healthcare through its investments is evident in its recent activities.
What are Rosetta Capital's investment criteria?
Rosetta Capital focuses on the life sciences and medical device sectors, investing at seed, Series A, Series B, and growth equity stages. The firm seeks companies that demonstrate potential for significant impact in healthcare.
How can I apply or pitch to Rosetta Capital?
Founders can pitch to Rosetta Capital by sending an email to info@rosettacapital.com. It is advisable to include a detailed business plan and financial projections in the pitch deck.
What makes Rosetta Capital different from other venture firms?
Rosetta Capital differentiates itself through its focus on direct secondary transactions, providing flexible liquidity solutions. The firm also emphasizes strategic engagement with portfolio companies, offering support beyond capital.
What is Rosetta Capital's geographic scope?
The firm primarily invests in North America and Europe, leveraging its extensive network and experience in these regions to identify promising investment opportunities.
What is Rosetta Capital's approach to post-investment involvement?
Rosetta Capital actively engages with its portfolio companies, providing support through follow-on financings and strategic management involvement. This approach helps ensure that companies are well-positioned for growth.
What is the typical check size for investments?
While specific check sizes are not disclosed, Rosetta Capital invests across various stages, indicating a flexible approach to funding based on the needs of the portfolio companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.